PIGNANI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 429
EU - Europa 158
AS - Asia 154
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 744
Nazione #
US - Stati Uniti d'America 426
CN - Cina 78
IT - Italia 75
TR - Turchia 29
DE - Germania 24
PL - Polonia 20
UA - Ucraina 16
SG - Singapore 13
ID - Indonesia 8
SE - Svezia 8
GB - Regno Unito 7
HK - Hong Kong 6
JP - Giappone 5
KR - Corea 5
IR - Iran 4
CA - Canada 3
VN - Vietnam 3
FI - Finlandia 2
NO - Norvegia 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
GE - Georgia 1
MY - Malesia 1
NL - Olanda 1
RU - Federazione Russa 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 744
Città #
Chandler 67
Fairfield 46
Ferrara 33
Izmir 29
Woodbridge 29
Houston 23
Nanjing 20
Warsaw 20
Ann Arbor 19
Wilmington 19
Seattle 17
Ashburn 16
Jacksonville 15
Princeton 14
Cambridge 13
Shanghai 13
New York 11
Milan 10
Dearborn 8
Singapore 8
Beijing 7
Jakarta 7
Piemonte 7
Bremen 6
Bologna 5
Changsha 5
Hebei 5
Cagliari 4
San Diego 4
Chicago 3
Dong Ket 3
Falls Church 3
Ferrara di Monte Baldo 3
Guangzhou 3
Jinan 3
Ningbo 3
Redwood City 3
Toronto 3
Alexandria 2
Andover 2
Belvedere Spinello 2
Hangzhou 2
Hong Kong 2
Leawood 2
London 2
Nanchang 2
Oslo 2
Seocho-gu 2
Seongbuk-gu 2
Tabriz 2
Zhengzhou 2
Augusta 1
Balk 1
Bloemfontein 1
Boardman 1
Brno 1
Chongqing 1
Dundee 1
Fars 1
Glenside 1
Haikou 1
Helsinki 1
Henderson 1
Hounslow 1
Jiaxing 1
Kunming 1
Los Angeles 1
Moscow 1
Munich 1
Nandlstadt 1
Newcastle 1
Paris 1
Persiceto 1
Porto Garibaldi 1
Prescot 1
Qingdao 1
Redmond 1
Rio De Janeiro 1
Sabz 1
San Mateo 1
Santa Clara 1
Seocho 1
Shaoxing 1
Shenyang 1
St Louis 1
Taipei 1
Tianjin 1
Triggiano 1
Varese 1
Totale 571
Nome #
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 145
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 107
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 100
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 70
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 64
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 60
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 53
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 52
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 43
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 43
Modulation at transcriptional and post-translational level to develop therapeutic approaches for coagulation factor deficiencies 23
Base and Prime editing of DNA as a new therapeutic option for Hemophilia A 16
New Genome Editing Approaches: Base And Prime Editing To Revert Hemophilia A-Causing Point Mutations 6
Totale 782
Categoria #
all - tutte 4.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 38 8 5 18 13 18 13 7 10 5 3 4
2020/2021104 1 4 2 9 4 2 20 17 16 12 11 6
2021/2022106 7 14 1 3 6 5 1 1 5 7 5 51
2022/2023137 13 21 1 20 21 16 11 7 17 1 5 4
2023/202492 7 9 10 2 7 12 5 6 1 6 5 22
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 782